AstraZeneca starts mid-stage TB drug trial in South Africa

AstraZeneca starts mid-stage TB drug trial in South Africa
LONDON (Reuters) - A new experimental drug that may fight drug-resistant strains of the lung disease tuberculosis is being tested in South Africa, where the first patient has been enrolled into a mid-stage clinical trial. AstraZeneca, which developed the medicine known as AZD5847, is working with the U.S. National Institute of Allergy and Infectious Diseases and Case Western Reserve University School of Medicine on the Phase IIa clinical study. ...
Source: news.yahoo.com